Materials
Heptaprenyl MurNAc pyrophosphate [1] [2] and Gram-negative Lipid II (1) 3 were prepared as previously described. Fluorescein isothiocyanate (FITC)-derivatized D-Lysine (FDL, 3) was prepared as previously described. 4 Full-length E. coli PBP1A was purified as reported previously, with modifications noted below. 3, [5] [6] The B. subtilis dacA deletion mutant was generated as part of the ARRA-funded knock out collection and its construction will be described elsewhere. Non-stick conical vials and pipet tips used for enzymatic reactions were from VWR. Primers were purchased from Integrated DNA Technologies.
Restriction endonucleases and T4 DNA ligase were purchased from New England Biolabs. All PCR amplification was performed with KOD Hot Start DNA polymerase from Novagen, and all plasmid preparation was conducted with Qiagen's spin miniprep kit. All other chemicals were purchased from Sigma Aldrich unless otherwise noted.
General Methods
NMR spectra were recorded on a Varian Inova 500 (500 MHz for 1 H and 125 MHz for 13 C) instrument in CD 3 OD or CDCl 3 . Chemical shifts are reported in units of parts per million (ppm). All reactions were conducted under nitrogen or argon atmosphere using anhydrous solvents passed through an activated alumina column, unless otherwise noted. Commercially available reagents were used without further purification. Low-resolution mass spectra (LRMS) were obtained on an Agilent Technologies 1100 series LC-MSD instrument using electrospray ionization (ESI). High-resolution mass spectra (HRMS) and LC/HRMS chromatograms were obtained on an Agilent Technologies 6520 LC/Q-TOF mass spectrometer. Reactions were monitored by thin layer chromatography on glass plates precoated with silica gel (250 µm, Merck) with detection by UV and cerium ammonium molybdate as the developing agent. Reactions were also monitored by LC/MS (Agilent Series 1100 instrument, using a Phenomenex Luna C18 3 mm column and ESI ionization.). Normal phase flash chromatography was carried out with silica gel from Sorbent Technologies (60 Å, 40-63 µm). Reverse phase flash chromatography was conducted on Phenomenex Strata C-18 SPE columns and Fluka C-18 reversed-phase silica. Highperformance lipid chromatography (HPLC) purification was carried out on an Agilent Technologies 1260 Quanternary LC system using Agilent Zorbax 300SB C18 and Phenomenex Luna C18 columns.
Scintillation counting of radioactive reactions was performed with a Beckman LS 6000 Series.
Fluorescence microscopy
Fluorescence microscopy experiments were conducted with a Nikon Eclipse Ti microscope equipped with a Plan Apochromat 100x/1.4NA oil phase contrast objective, a Chroma 49002 ET-EGFP filter cube, and a CoolSnapHQ 2 digital camera (Photometrics). The light source was a Lumencor SpectraX-6 LCR SA light engine. Images were captured using Nikon Elements software and processed using Fiji.
All fluorescence images were scaled equally for comparison. For conditions that produced a weaker fluorescent signal, an autoscaled image was generated to highlight the staining pattern.
B. subtilis strains (168: Figures 4, S2, S5
; 168 ∆dacA: Figure S6 ; 3610: Figure S7) were grown in the presence and absence of probe 3 or 4 at designated concentrations (10 -500 µM) in CH medium. Exponentially growing cells were centrifuged at 8,000 RPM for 1 min, washed 3 times in CH medium, spotted onto agarose pads, and imaged immediately. E. coli MC4100 cells were grown to exponential phase in the presence and absence of probe 3 or 4 (500 µM) in M9 glucose media and washed with PBS. Prior to imaging, cells were immobilized on pads composed of 2% agarose ( Figure   S4 ).
(R)-benzyl (1-oxo-1-(tritylamino)pent-4-en-2-yl)carbamate (Cbz-D-allylglycine-NHTrt, SI-1)
To a stirring mixture of (R)- mg, 0.168 mmol). After 2 h, the mixture was concentrated and partitioned with EtOAc (20 mL), and 10% citric acid (10 mL). The organic phase was subsequently washed with H 2 O (10 mL), 5% NaHCO 3 (10 mL), brine (10 mL), dried over anhy. Na 2 SO 4 , and concentrated. The residue was purified via silica gel column chromatography (step gradient: CHCl 3 , 1% MeOH in CHCl 3 , 5% MeOH in CHCl 3 ) to afford 
Boc-L-Ala-γ-D-Glu(OMe)-meso-2(L),2'(D)-DAP(TFA)(NHTrt)-D-Ala-D-Ala-OMe (SI-4)
A mixture of SI-3 (10 mg, 0.010 mmol) and 20% Pd(OH) 2 /C (4 mg) in MeOH (0.5 mL) was stirred under H 2 (1 atm) for 35 min. The mixture was filtered through Celite and concentrated to afford the free base Figure S21) .
B. subtilis Lipid II (2)
B. subtilis Lipid I (SI-5) was converted to 2 using a previously described enzymatic method. 
residue was partitioned between DCM (30 mL) and sat. NaHCO 3 (10 mL). The organic layer was washed with sat. NaHCO 3 (2X 10 mL), water (10 mL), 5% citric acid (2X 10 mL), then brine (10 mL).
The organic layer was then dried over anhy. Na 
Cloning of wild-type B. subtilis PBP1
The subtilils ponA-His 6 was transformed into NovaBlue cells and confirmed by DNA sequencing (Beckman Coulter and Genewiz).
Cloning of transpeptidase-inactive B. subtilis PBP1
The catalytic serine residue (Ser390) of the transpeptidase domain of B. subtilis PBP1 has been identified by sequence alignment with other PBPs. 11 A Ser390Ala mutation was installed into pJM25 by site-directed mutagenesis with forward primer 5'-CAC AGC CTG GTG CGA CCA TAA AAC -3' and reverse primer 5'-GTT TTA TGG TCG CAC CAG GCT GTG -3'. The final construct (pJM34) was transformed into NovaBlue cells and confirmed by DNA sequencing.
Purification of wild-type and TP-inactive B. subtilis PBP1
Plasmids pJM25 (wild-type PBP1) and pJM34 (TP-inactive PBP1) were transformed into E. coli 
Purification of wild-type and TP-inactive E. coli PBP1A
Full-length E. coli PBP1A was purified as reported previously. To prepare the nickel columns, 3 mL of Ni-NTA Superflow resin (Qiagen) slurry were washed and equilibrated with column buffer (20 mM Tris-HCl, pH 7.5, 0.5 M NaCl, 0.1% reduced Triton X-100).
The supernatants were filtered (0.45 µM filter, VWR), supplemented with 2 mM imidazole, and incubated with the resins for 1.5 h at 4°C, rocking. The resins were collected and washed with 30 mL of column buffer plus 50 mM imidazole. The proteins were eluted from the resins with 10 mL column buffer with 300 mM imidazole. As described previously, His 6 -SUMO protease (25 µL of a 10 mg/mL stock) was added to the elution fractions to cleave off the His 6 -SUMO tag from PBP1A. 12 The samples were loaded into 10 KDa MWCO Slide-A-Lyzer dialysis cassettes and each dialyzed against 1.8 L of dialysis buffer (20 mM Tris-HCl, pH 7.5, 0.5 M NaCl, 0.1% reduced Triton-X-100) overnight at 4°C. To separate the cleaved PBP1A from the His 6 -SUMO tag and protease, the dialyzed samples were again incubated with 3 mL equilibrated Ni-NTA resins for 1 h at 4°C.
The flow-through fractions were collected and concentrated to 0.5 mL in Amicon Ultra 10 kDa MWCO centrifugal filter units and further purified by FPLC on a Superdex 200 column (buffer: 20 mM Tris-HCl, pH 7.5, 0.5 M NaCl, 0.1% reduced Triton X-100, 10% glycerol; flow-rate: 0.5 mL/min).
Fractions were analyzed by SDS-PAGE, and those containing PBP1A were pooled and concentrated to 0.5 mL in 10 kDa MWCO centrifugal filter units. Protein concentrations were determined with the Thermo NanoDrop A280 function, and both the wild-type and the TP-inactive preparations were found to be approximately 18 µM. Proteins were stored at -80°C. Table S1 for ion masses and
LC/HRMS assay to evaluate in vitro
Figures S9 and S10 for HRMS spectra.
Isolation and analysis of B. subtilis cell wall from culture
Bacillus subtilis 3610 was grown in 1-L LB Miller medium in the presence and absence of D-Phe or DPhe-NH 2 (0.5 mM final concentration) with shaking at 37 °C to mid log phase (3.5 h). The cells were frozen at -80°C, and cell wall was isolated from the culture as described by Glauner et al. 13 and Uehera et al. 14 with modifications described below. The cells were resuspended in 10 mL Tris-buffered-saline and boiled for 30 min in 50 mL 5% SDS (sodium dodecyl sulfate). After the samples cooled, they were pelleted in the ultracentrifuge (100,000 xg, 25°C, 30-90 min) and washed six times by pelleting (100,000 xg, 25°C, 30-90 min) from 20 mL water aliquots to remove the SDS. The samples were resuspended in 600 µL digestion buffer (100 mM Tris-HCl, 20 mM MgSO 4 , pH 7.5), treated with 2 µL DNAse I, 4 µL RNAse A, and 8 µL alpha-amylase (all stocks 10 mg/mL in 50% glycerol), and incubated at 37°C with shaking for 2 h. To cleave proteins attached to the cell wall, CaCl 2 (10 mM final concentration) and trypsin (8 µL of a 10 mg/mL stock in 50% glycerol) were added, and the samples were incubated at 37°C with shaking overnight. An additional aliquot of trypsin was added, and the samples were digested for an additional night. To remove the trypsin, SDS was added to a final concentration of 1%, and the samples were incubated at 95°C for one h. The samples were again Table S1 . Ions extracted in Figures 2, 3 , and S8. 
